Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $10494.4.

  • Molecular Partners Ag's Accumulated Expenses rose 3296.69% to $10494.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $10494.4, marking a year-over-year increase of 3296.69%. This contributed to the annual value of $8762.8 for FY2024, which is 9989.7% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Accumulated Expenses stood at $10494.4, which was up 3296.69% from $11721.4 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Accumulated Expenses ranged from a high of $10.8 million in Q4 2021 and a low of $5256.6 during Q1 2023
  • Moreover, its 5-year median value for Accumulated Expenses was $9647.2 (2024), whereas its average is $3.1 million.
  • Per our database at Business Quant, Molecular Partners Ag's Accumulated Expenses crashed by 9989.66% in 2024 and then surged by 3296.69% in 2025.
  • Over the past 5 years, Molecular Partners Ag's Accumulated Expenses (Quarter) stood at $10.8 million in 2021, then dropped by 28.02% to $7.8 million in 2022, then grew by 9.27% to $8.5 million in 2023, then tumbled by 99.9% to $8800.0 in 2024, then grew by 19.25% to $10494.4 in 2025.
  • Its Accumulated Expenses stands at $10494.4 for Q3 2025, versus $11721.4 for Q2 2025 and $5949.4 for Q1 2025.